What chest CT findings are typical in interstitial lung disease secondary to immune‑checkpoint inhibitor immunotherapy?

Chest CT Findings in ILD Secondary to Immunotherapy

Immune checkpoint inhibitor-related interstitial lung disease (ICI-ILD) most commonly presents with an organizing pneumonia (OP) pattern on chest CT, characterized by multifocal patchy alveolar opacities with peribronchovascular and/or peripheral distribution, though multiple distinct radiologic patterns can occur. 1

Primary CT Patterns

The 2021 Fleischner Society position paper identifies five major CT patterns for drug-related pneumonitis from immune checkpoint inhibitors 1:

1. Organizing Pneumonia (OP) Pattern - Most Common

• Multifocal patchy alveolar opacities with peribronchovascular and/or peripheral distribution
• May demonstrate reversed halo sign
• This is the predominant pattern seen with ICI therapy 1
• Associated with mild disease and favorable outcomes 2, 3
• Research confirms OP pattern in approximately 47.5% of ICI-ILD cases 4

2. Nonspecific Interstitial Pneumonia (NSIP) Pattern

• Patchy areas of ground-glass opacity (GGO) starting peripherally
• Progression to irregular reticular opacities, architectural distortion, and traction bronchiectasis
• Bilateral and symmetric with predominant lower-lung involvement 1
• May include associated areas of consolidation

3. Hypersensitivity Pneumonitis (HP) Pattern

• Poorly defined small centrilobular nodules
• Bilateral ground-glass opacity
• Large or lobular areas of decreased attenuation and vascularity (mosaic attenuation) 1

4. Diffuse Alveolar Damage (DAD/ARDS) Pattern - Most Serious

• Extensive bilateral areas of GGO and dependent airspace consolidation in exudative phase
• Traction bronchiectasis and decreased lung volumes in organizing/fibrotic phases 1
• Critical prognostic significance: This pattern is associated with serious clinical outcomes and high mortality 1
• Research demonstrates DAD pattern in 31.1% of ICI-ILD cases with significantly worse prognosis (median OS 334 days vs 1316 days for non-DAD patterns) 4
• All patients with DAD pattern showed grade 3 or higher severity, with potential for grade 5 (fatal) outcomes 5

5. Simple Pulmonary Eosinophilia Pattern

• Nonsegmental consolidation or GGO, unilateral or bilateral
• Transient and migratory characteristics
• Spontaneous resolution within 4 weeks is common
• Excellent prognosis 1

Key Imaging Characteristics

Distribution Patterns

According to ASCO guidelines, ground-glass opacities or patchy nodular infiltrates, predominantly in the lower lobes, are common findings 6. The radiologic abnormalities are often focal and very different from the diffuse pneumonitis associated with targeted agents 6.

Laterality and Symmetry

• Bilateral involvement is typical across most patterns 1, 6
• Lung cancer patients more commonly exhibit asymmetrical shadows compared to non-lung cancer patients 7
• Non-lung cancer patients more likely to show symmetrical infiltrations 7

Additional Features

• Pleural effusions may be present 3
• Sarcoid-like granulomatous reactions with subpleural micro-nodular opacities and hilar lymphadenopathy can occur 6
• Some cases demonstrate moving or relapsing patterns over time 7

Critical Clinical Correlations

Prognostic Implications by Pattern

The DAD pattern requires immediate recognition as it predicts short-term adverse prognosis 5. Research shows:

• DAD pattern: severe respiratory symptoms, diffuse GGOs, poor prognosis with potential fatal outcomes 2
• OP pattern: less severe symptoms, consolidations/patchy opacities, favorable response to treatment with remission within months 2

Timing Considerations

• Lung cancer patients: earlier onset (median 78 days) 7
• Non-lung cancer patients: later onset (median 186 days) 7
• Some cases present as insidiously progressive ICI-ILD that develops unnoticed and progresses gradually to respiratory failure 8

Common Pitfalls and Caveats

Diagnostic Challenges

1. CT patterns are nonspecific for either drug reaction in general or reaction to a particular drug 1
2. Diagnosis requires combination of clinical, radiologic, and histologic findings in context of ICI exposure 1
3. Multiple patterns may coexist; report the dominant pattern 1
4. Must exclude infections and metastatic disease as alternative diagnoses 1

Monitoring Requirements

• Thin-section CT scans (2.0-2.5 mm or less) with IV contrast recommended 1
• Both transverse and coronal reformatted images needed for thorough analysis 1
• Serial imaging is essential to observe pneumonitis activity and detect insidiously progressive disease 7, 8
• In insidiously progressive cases, C-reactive protein levels and ILD extent gradually increase over multiple treatment cycles before recognition 8

Risk Stratification

Higher risk populations include:

• Patients with preexisting emphysema (OR 2.81) or interstitial lung abnormalities (OR 1.98) 9
• Prior thoracic radiotherapy (OR 4.10) 9
• Patients with extensive ILA or honeycombing at baseline 9
• Combination ICI therapy shows higher incidence (10%) versus monotherapy (3%) 6

Pattern Recognition for Outcomes

Recognize that non-organizing pneumonia patterns and weak response to corticosteroids are warning signs for potentially fatal outcomes 8. The presence of consolidation and traction bronchiectasis in lung cancer patients suggests more aggressive disease 7.